Ji‐Wang Chern
Ji‐Wang Chern publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Quinazolinone synthesis and applications, Synthesis and Characterization of Heterocyclic Compounds and Synthesis and Biological Evaluation.
- World rank
- #4,960,331 of 7,710,434 ranked researchers
- Rank in Taiwan
- #37,845 of 57,035
- Works
- 171
- Citations
- 2.7k
- Citations per work
- 15.8
What does Ji‐Wang Chern research?
Ji‐Wang Chern's work is mostly in Chemistry (44%), Biochemistry, Genetics and Molecular Biology (23%), Medicine (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences7543.7%
- Chemistry7543.7%
- Life Sciences3922.6%
- Everything else3721.5%
- Health Sciences2112.2%
- Medicine2112.2%
- 1Organic Chemistry44% of their works
- 2Molecular Biology23% of their works
- 3Oncology4% of their works
- 4Infectious Diseases3% of their works
- 5Pharmacology2% of their works
- 6Radiology, Nuclear Medicine and Imaging2% of their works
Research topics
- Quinazolinone synthesis and applications
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and biological activity
- Biochemical and Molecular Research
- HIV/AIDS drug development and treatment
- Histone Deacetylase Inhibitors Research
Which keywords describe Ji‐Wang Chern's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Anticancer, Antimicrobial, Heterocyclic Compounds, Medicinal Chemistry, Indirubin and Quinazoline.
- Histone Deacetylases
- Nucleotide Metabolism
- Enzyme Regulation
- Vascular Targeting Agents
- Phenothiazines
- Quinoxaline
- Triazines
- Quinazoline
- Medicinal Chemistry
- Antimicrobial
- Biological Evaluation
- Synthesis
- Anticancer
- Heterocyclic Compounds
- Indirubin
- Drug Discovery
- Antimicrobial Activity
- Biological Activities
- Tubulin Inhibitors
- Antiretroviral Therapy
- HIV Infection
- HDAC Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Synthesis1584 topics
- Biological Evaluation1343 topics
- Anticancer1193 topics
- Antimicrobial1193 topics
- Heterocyclic Compounds592 topics
- Medicinal Chemistry592 topics
- Indirubin551 topic
- Quinazoline551 topic
- Drug Discovery401 topic
- Triazines401 topic
- Antimicrobial Activity391 topic
- Quinoxaline391 topic
- Biological Activities241 topic
- Phenothiazines241 topic
- Tubulin Inhibitors201 topic
- Vascular Targeting Agents201 topic
- Antiretroviral Therapy171 topic
- Enzyme Regulation171 topic
- HIV Infection171 topic
- Nucleotide Metabolism171 topic
- HDAC Inhibitors121 topic
- Histone Deacetylases121 topic
Where does Ji‐Wang Chern work?
Ji‐Wang Chern's main affiliation in the publication record is National Taiwan University, Taiwan.
How many publications and citations does Ji‐Wang Chern have?
OpenAlex counts 171 works and 2,696 citations for Ji‐Wang Chern, an h-index of 29, ranking #4,960,331 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ji‐Wang Chern. Posts are plain text and can be reported.